These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19891889)

  • 21. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT; Yadav PD; Khare A; Khan AH
    Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety considerations in laboratory design.
    Mortland KK; Mortland DB
    Clin Leadersh Manag Rev; 2003; 17(3):175-7. PubMed ID: 12813961
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk-Based Reboot: New WHO Guidance for Laboratory Biosafety.
    Albtoush N; Noguez JH
    Clin Chem; 2018 Oct; 64(10):1544-1545. PubMed ID: 32100859
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
    Shurtleff AC; Garza N; Lackemeyer M; Carrion R; Griffiths A; Patterson J; Edwin SS; Bavari S
    Viruses; 2012 Dec; 4(12):3932-51. PubMed ID: 23342380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15.
    Bjork A; Sosin DM
    Health Secur; 2017; 15(6):587-598. PubMed ID: 29193983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety lapses are common in US labs that handle deadly pathogens, experts tell Congress.
    McCarthy M
    BMJ; 2014 Jul; 349():g4679. PubMed ID: 25035286
    [No Abstract]   [Full Text] [Related]  

  • 27. Health and safety in the medical laboratory.
    Drury P
    Can J Med Technol; 1988 Aug; 50(3):177-81. PubMed ID: 10289978
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishing a national biological laboratory safety and security monitoring program.
    Blaine JW
    Biosecur Bioterror; 2012 Dec; 10(4):396-400. PubMed ID: 23210833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.
    Reusken CB; Mögling R; Smit PW; Grunow R; Ippolito G; Di Caro A; Koopmans M
    Euro Surveill; 2018 May; 23(19):. PubMed ID: 29766839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Employee Safety and Biosafety Applications in Microbiology Laboratories; A Multicenter Evaluation in Turkey].
    Köroğlu M; Altındiş S; Aydemir Ö; Yüksel B; Demiray T; Erkorkmaz Ü; Aslan FG; Otlu B; Altındiş M;
    Mikrobiyol Bul; 2020 Jul; 54(3):347-367. PubMed ID: 32755513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodefence lab criticized.
    Dolgin E
    Nature; 2009 Jul; 460(7255):556-7. PubMed ID: 19641559
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current biosafety in clinical laboratories in Japan: report of questionnaires' data obtained from clinical laboratory personnel in Japan].
    Goto M; Yamashita T; Misawa S; Komori T; Okuzumi K; Takahashi T
    Kansenshogaku Zasshi; 2007 Jan; 81(1):39-44. PubMed ID: 17338315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan.
    Elduma AH
    Pan Afr Med J; 2012; 11():19. PubMed ID: 22514753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological safety in the medical laboratory.
    Lo J
    Hong Kong Med J; 2015 Jun; 21(3):200. PubMed ID: 26045068
    [No Abstract]   [Full Text] [Related]  

  • 35. Validated Methods for Removing Select Agent Samples from Biosafety Level 3 Laboratories.
    Kesterson AE; Craig JE; Chuvala LJ; Heine HS
    Emerg Infect Dis; 2020 Nov; 26(11):2586-2590. PubMed ID: 33079040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosafety and biosecurity in veterinary laboratories.
    Brass VH; Astuto-Gribble L; Finley MR
    Rev Sci Tech; 2017 Aug; 36(2):701-709. PubMed ID: 30152450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosafety considerations for autopsy.
    Nolte KB; Taylor DG; Richmond JY
    Am J Forensic Med Pathol; 2002 Jun; 23(2):107-22. PubMed ID: 12040252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-based reboot for global lab biosafety.
    Kojima K; Booth CM; Summermatter K; Bennett A; Heisz M; Blacksell SD; McKinney M
    Science; 2018 Apr; 360(6386):260-262. PubMed ID: 29674576
    [No Abstract]   [Full Text] [Related]  

  • 39. Biosafety considerations for flow cytometric analysis of human immunodeficiency virus-infected samples.
    Schmid I; Kunkl A; Nicholson JK
    Cytometry; 1999 Oct; 38(5):195-200. PubMed ID: 10516605
    [No Abstract]   [Full Text] [Related]  

  • 40. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
    Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
    Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.